Investigation reveals dementia risk linked to blood-brain barrier-crossing ACE inhibitors in people living with HIV, highlighting therapeutics for neurocognitive decline.
The decreased mortality of people with HIV (PWH) has revealed non-HIV-associated comorbidities such as neurocognitive disorders (e.g., dementia). There is an urgency to discover therapeutics to prevent or delay neurocognitive decline among PWH.
No takes yet. Share an insight, caveat, or question.
Cummings et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: